Aggarwal Sumit 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jan 27, 2023
Insider Transaction Report
Form 4
Aggarwal Sumit
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-01-25+68,700→ 68,700 totalExercise: $4.27Exp: 2033-01-25→ Common Stock (68,700 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.